Exploratory Clinical Study on the Safety and Efficacy of Anti- CD19/BCMA U CAR-T Cell Injection for the Treatment of Relapsed/Refractory Autoimmune Diseases

Abroad (travel likely)RecruitingEARLY_PHASE1

Conditions

Autoimmune Diseases · Systemic Lupus Erythematosus · Systemic Sclerosis · Primary Sjögren Syndrome · Rheumatoid Arthritis · Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Changhai Hospital, Shanghai, China
Contact: Study coordinator (Dongbao Dongbao Zhao, Doctor) · dongbaozhao@163.com · +86-15921061314

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

US Zamto-cel Autoimmune Diseases

Lupus Nephritis · Systemic Lupus Erythematosus · Systemic Sclerosis (SSc)

Abroad (travel likely)RecruitingPHASE1

Milwaukee, United States

A Study to Evaluate the Safety and Activity of SAR448501/DR-0201 in Patients With Autoimmune Rheumatic Diseases

Systemic Lupus Erythematosus (SLE) · Rheumatoid Arthritis (RA)

Abroad (travel likely)RecruitingPHASE1

Brisbane, Australia · Melbourne, Australia

Phase I/II Study of AD-PluReceptor Plus Tafasitamab-cxix and Lymphodepleting Chemotherapy in Patients With Autoimmune Disorders

Autoimmune Disorders · Systemic Sclerosis · Systemic Lupus Erythematosus

Abroad (travel likely)RecruitingPHASE1, PHASE2

Houston, United States · Houston, United States

A Study to Evaluate the Safety, Tolerability, and Preliminary Efficacy of NEUK203-215 Injection in Adult Chinese Patients With Relapsed/Refractory Autoimmune Diseases

Autoimmune

Abroad (travel likely)RecruitingEARLY_PHASE1

Shanghai, China